Page 138 - Read Online

Page 12 of 13 De Gaspari et al. Vessel Plus 2022;6:57 https://dx.doi.org/10.20517/2574-1209.2022.05

53. Sikkink LA, Ramirez-Alvarado M. Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture. Cell Death Dis
2010;1:e98. DOI
54. Mishra S, Guan J, Plovie E, et al. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early
mortality in zebrafish. Am J Physiol Heart Circ Physiol 2013;305:H95-103. DOI PubMed PMC
55. Dittloff KT, Iezzi A, Zhong JX, Mohindra P, Desai TA, Russell B. Transthyretin amyloid fibrils alter primary fibroblast structure,
function, and inflammatory gene expression. Am J Physiol Heart Circ Physiol 2021;321:H149-60. DOI PubMed PMC
56. Siegismund CS, Escher F, Lassner D, et al. Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL
amyloidosis. Eur J Heart Fail 2018;20:751-7. DOI PubMed
57. Kotecha T, Martinez-Naharro A, Treibel TA, et al. Myocardial Edema and Prognosis in Amyloidosis. J Am Coll Cardiol
2018;71:2919-31. DOI PubMed
58. Lim HE, Pak HN, Kim YH. Acute myocarditis associated with cardiac amyloidosis manifesting as transient complete atrioventricular
block and slow ventricular tachycardia. Int J Cardiol 2006;109:395-7. DOI PubMed
59. Basso C, Leone O, Rizzo S, et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular
pathology study. Eur Heart J 2020;41:3827-35. DOI PubMed PMC
60. Bois MC, Boire NA, Layman AJ, et al. COVID-19-Associated Nonocclusive Fibrin Microthrombi in the Heart. Circulation
2021;143:230-43. DOI PubMed PMC
61. Bandera F, Martone R, Chacko L, et al. Clinical importance of left atrial infiltration in cardiac transthyretin amyloidosis. JACC
Cardiovasc Imaging 2022;15:17-29. DOI PubMed PMC
62. Lool L. Isolated atrial amyloidosis: a clinicopathologic study indicating increased prevalence in chronic heart disease. Human
Pathology 1993;24:602-7. DOI PubMed
63. Fayyaz AU, Bois MC, Dasari S, et al. Amyloidosis in surgically resected atrial appendages: a study of 345 consecutive cases with
clinical implications. Mod Pathol 2020;33:764-74. DOI PubMed
64. Kaye GC, Butler MG, d'Ardenne AJ, Edmondson SJ, Camm AJ, Slavin G. Isolated atrial amyloid contains atrial natriuretic peptide: a
report of six cases. Br Heart J 1986;56:317-20. DOI PubMed PMC
65. Pucci A, Wharton J, Arbustini E, et al. Atrial amyloid deposits in the failing human heart display both atrial and brain natriuretic
peptide-like immunoreactivity. J Pathol 1991;165:235-41. DOI PubMed
66. Wittich CM, Neben-Wittich MA, Mueller PS, Gertz MA, Edwards WD. Deposition of amyloid proteins in the epicardial coronary
arteries of 58 patients with primary systemic amyloidosis. Cardiovasc Pathol 2007;16:75-8. DOI PubMed
67. Smith RR, Hutchins GM. Ischemic heart disease secondary to amyloidosis of intramyocardial arteries. The American Journal of
Cardiology 1979;44:413-7. DOI PubMed
68. Saffitz JE, Sazama K, Roberts WC. Amyloidosis limited to small arteries causing angina pectoris and sudden death. The American
Journal of Cardiology 1983;51:1234-5. DOI PubMed
69. Barbour DJ, Roberts WC. Frequency of acute and healed myocardial infarcts in fatal cardiac amyloidosis. The American Journal of
Cardiology 1988;62:1134-5. DOI PubMed
70. Pasotti M, Agozzino M, Concardi M, Merlini G, Rapezzi C, Arbustini E. Obstructive intramural coronary amyloidosis: a distinct
phenotype of cardiac amyloidosis that can cause acute heart failure. Eur Heart J 2006;27:1810. DOI PubMed
71. Damy T, Jaccard A, Guellich A, et al. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis. Amyloid
2016;23:194-202. DOI PubMed
72. Kristen AV, Maurer MS, Rapezzi C, Mundayat R, Suhr OB, Damy T. THAOS investigators. Impact of genotype and phenotype on
cardiac biomarkers in patients with transthyretin amyloidosis - report from the Transthyretin Amyloidosis Outcome Survey (THAOS).
PLoS One 2017;12:e0173086. DOI PubMed PMC
73. Olson LJ, Gertz MA, Edwards WD, et al. Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial
biopsy and immunohistochemistry. N Engl J Med 1987;317:738-42. DOI PubMed
74. Cornwell GG 3rd, Westermark P, Murdoch W, Pitkänen P. Senile aortic amyloid. A third distinctive type of age-related cardiovascular
amyloid. Am J Pathol 1982;108:135-9. PubMed PMC
75. Mucchiano G, Cornwell GG 3rd, Westermark P. Senile aortic amyloid. Evidence for two distinct forms of localized deposits. Am J
Pathol 1992;140:871-7. PubMed PMC
76. Häggqvist B, Näslund J, Sletten K, et al. Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the
most common human amyloid. Proc Natl Acad Sci U S A 1999;96:8669-74. DOI PubMed PMC
77. Peng S, Glennert J, Westermark P. Medin-amyloid: a recently characterized age-associated arterial amyloid form affects mainly
arteries in the upper part of the body. Amyloid 2005;12:96-102. DOI PubMed
78. Goffin Y. Microscopic amyloid deposits in the heart valves: a common local complication of chronic damage and scarring. J Clin
Pathol 1980;33:262-8. DOI PubMed PMC
79. Cooper JH. Localized dystrophic amyloidosis of heart valves. Human Pathology 1983;14:649-53. DOI
80. Ladefoged C, Rohr N. Amyloid deposits in aortic and mitral valves. A clinicopathological investigation of material from 100
consecutive heart valve operations. Virchows Arch A Pathol Anat Histopathol 1984;404:301-12. DOI PubMed
81. Kristen AV, Schnabel PA, Winter B, et al. High prevalence of amyloid in 150 surgically removed heart valves--a comparison of
histological and clinical data reveals a correlation to atheroinflammatory conditions. Cardiovasc Pathol 2010;19:228-35. DOI
PubMed